MYOVIEW 30ML

Peak

tetrofosmin

NDAINJECTIONINJECTABLE
Approved
Feb 1996
Lifecycle
Peak
Competitive Pressure
8/100

Mechanism of Action

(99mTc) tetrofosmin is a lipophilic, cationic complex which diffuses passively through the cell membrane and is locally retained actively due to the presence of intact mitochondria reflecting the presence of viable cells. After intravenous injection, it is distributed within the myocardium…

Loss of Exclusivity

LOE Date
Mar 10, 2030
48 months away
Patent Expiry
Mar 10, 2030

Patent Records (1)

Patent #ExpiryTypeUse Code
9549999
Mar 10, 2030
Product
—
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history